VSee Health (VSEE)
NASDAQ:VSEE
Want to see VSEE full AI Analyst Report?
VSEE Stock Chart & Stats
$0.38
-$0.02(-1.82%)
At close: 4:00 PM EST
$0.38
-$0.02(-1.82%)
Day’s Range― - ―
52-Week Range$0.17 - $2.52
Previous CloseN/A
Volume71.92K
Average Volume (3M)1.90M
Market Cap
$8.30M
Enterprise Value$24.53K
Total Cash (Recent Filing)$5.27M
Total Debt (Recent Filing)$2.44M
Price to Earnings (P/E)―
Beta0.44
Next Earnings
Sep 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.73
Shares Outstanding47,299,420
10 Day Avg. Volume5,577,105
30 Day Avg. Volume1,899,699
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)1.38
Price to Sales (P/S)0.52
P/FCF Ratio-2.17
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.24
Revenue Forecast (FY)$21.60M
Bulls Say, Bears Say
Bulls Say
Revenue GrowthRevenue growth (~46% in 2025 after strong gains in 2024) shows accelerating adoption of VSee’s telehealth platform and expanding recurring subscription base. Durable top-line momentum supports scale economies, improving unit economics and the company’s ability to invest toward eventual profitability.
Gross MarginA ~50% gross margin in 2025 reflects software-led economics and meaningful product-level profitability. Sustained gross margins enable reinvestment in R&D and customer success while preserving unit economics, providing a structural advantage that can deliver operating leverage as revenue scales.
Strategic Partnership & Equity StakeThe multi-year managed services deal with GoMyRx plus a $2.0M purchase for a 10% stake aligns VSee strategically and financially with a complementary prescription platform. That contract (through 2027, extendable) creates recurring fee revenue, cross-sell opportunities, and strengthens VSee’s ecosystem positioning.
Bears Say
Negative Cash FlowOperating and free cash flow were negative each year from 2021–2025, with roughly -$3.5M free cash flow in 2025. Persistent cash burn forces repeated financing, constrains strategic investments and hiring, elevates dilution risk, and limits flexibility until operating cash flow turns positive.
Sustained LossesDespite revenue growth and solid gross margins, the company remains deeply unprofitable (net margin ~ -101% in 2025). Continued large losses and weak earnings quality produce poor returns on equity and mean long-term shareholder value depends on sustained operating improvements and strict cost control.
Dilution Risk From Warrant IssuanceShareholder approval authorizes issuance of shares to warrant holders for up to 19,672,130 shares, creating material dilution risk. A large, warrant-linked equity issuance can substantially increase share count, weaken per-share economics, and signals reliance on equity capital rather than sustainable operating cash flow.
VSee Health News
VSEE FAQ
What was VSee Health’s price range in the past 12 months?
VSee Health lowest stock price was $0.17 and its highest was $2.52 in the past 12 months.
What is VSee Health’s market cap?
VSee Health’s market cap is $8.30M.
When is VSee Health’s upcoming earnings report date?
VSee Health’s upcoming earnings report date is Sep 28, 2026 which is in 143 days.
How were VSee Health’s earnings last quarter?
Currently, no data Available
Is VSee Health overvalued?
According to Wall Street analysts VSee Health’s price is currently Overvalued.
Does VSee Health pay dividends?
VSee Health does not currently pay dividends.
What is VSee Health’s EPS estimate?
VSee Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does VSee Health have?
VSee Health has 47,299,420 shares outstanding.
What happened to VSee Health’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of VSee Health?
Currently, no hedge funds are holding shares in VSEE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
VSee Health
VSee Health, Inc. provides telehealth care solutions. The company offers iDoc Telehealth solutions that treat and coordinate care for acutely ill patients in the neurointensive care, cardiac intensive care, and intensive care units for stroke, spinal cord, brain trauma, and other neurological conditions. Its telehealth platform provides a set of building blocks to solve needs of clients. VSee Health, Inc. is headquartered in Newton, Massachusetts.
Technical Analysis
Ownership Overview
11.65% Insiders
0.16% Mutual Funds
0.03% Other Institutional Investors
87.71% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---